Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al

Dan Turner*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageAmerican English
Pages (from-to)E42
JournalInflammatory Bowel Diseases
Issue number5
StatePublished - 11 Apr 2020
Externally publishedYes

Bibliographical note

Funding Information:
From the *Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel Supported by: This study was supported by a grant from the Leona M. and Harry B. Helmsley Charitable Trust.

Cite this